Large between-patient variability in egfr decline before clinical trial enrollment and impact on atrasentan’s efficacy: a post hoc analysis from the SONAR trial

  1. Waijer, S.W.
  2. de Vries, S.T.
  3. Busch, R.
  4. Xie, D.
  5. Gansevoort, R.T.
  6. Hou, F.F.
  7. Gorriz, J.L.
  8. Laverman, G.D.
  9. de Nicola, L.
  10. Pascual, J.
  11. Provenzano, M.
  12. Pergola, P.E.
  13. Tang, S.C.W.
  14. Wanner, C.
  15. Zaoui, P.
  16. Parving, H.-H.
  17. de Zeeuw, D.
  18. Heerspink, H.J.L.
Revista:
Journal of the American Society of Nephrology

ISSN: 1533-3450,  1046-6673

Ano de publicación: 2021

Volume: 32

Número: 11

Páxinas: 2731-2734

Tipo: Artigo

DOI: 10.1681/ASN.2021040498 GOOGLE SCHOLAR lock_openAcceso aberto editor
Fonte de datos: Scopus